步长制药：推动中药出海及生物药国际化

Core Viewpoint - The company is addressing macro challenges such as declining birth rates and reduced consumer willingness by expanding into chemical drugs, biological drugs, and vaccines based on traditional Chinese medicine [1] Group 1: Strategic Focus - The company will focus on major diseases related to aging, such as cardiovascular and oncology, while enhancing the competitiveness of its unique products and evidence-based medical research [1] - The company aims to accelerate its global expansion, promoting the internationalization of traditional Chinese medicine and biological drugs [1] Group 2: Collaborative Development - The company is actively participating in centralized procurement and building a multi-field collaborative research and development pipeline, as well as a diversified product structure [1] - The strategy aims to reduce reliance on single policies and achieve sustainable growth [1]